Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool-Reference-Cited by-同舟云学术

Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool

Published:2022-04 Issue:4 Volume:30 Page:407-413
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Alshehail Bashayer,Al Jamea Zainab,Chacko Royes,Alotaibi Fawaz,Ismail Nadia,Alshayban Dhafer

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference34 articles.

1. Liver injury in COVID-19: The current evidence;Alqahtani;United European Gastroenterol. J.,2020

2. American Diabetic Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020, 2020. Diabetes Care. 43,S66-S76. https://doi.org/10.2337/dc20-S006

3. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia;Aldryhim;Expert Opin. Drug Saf.,2019

4. Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting;Abdul Hadi;Integr. Pharm. Res. Pract.,2017

5. Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients;Chouchana;Ther. Drug Monit.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse drug events among hospitalized COVID-19 patients. Experience with the Global Trigger Tool;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2024-04-19

2. Favipiravir Protects Enterocytes From Cell Death After Inflammatory Storm;Cureus;2023-10-21

3. Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators;Healthcare;2023-02-23

4. Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review;Safety and Risk of Pharmacotherapy;2022-12-29